279 related articles for article (PubMed ID: 27854395)
1. Prediction of stillbirth from placental growth factor at 19-24 weeks.
Aupont JE; Akolekar R; Illian A; Neonakis S; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):631-635. PubMed ID: 27854395
[TBL] [Abstract][Full Text] [Related]
2. Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19-24 weeks.
Akolekar R; Tokunaka M; Ortega N; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):624-630. PubMed ID: 27854387
[TBL] [Abstract][Full Text] [Related]
3. Prediction of stillbirth from placental growth factor at 11-13 weeks.
Akolekar R; Machuca M; Mendes M; Paschos V; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):618-623. PubMed ID: 27854388
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation.
Ashoor G; Syngelaki A; Papastefanou I; Nicolaides KH; Akolekar R
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):61-68. PubMed ID: 34643306
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
[TBL] [Abstract][Full Text] [Related]
6. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks.
Mastrodima S; Akolekar R; Yerlikaya G; Tzelepis T; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):613-617. PubMed ID: 27561595
[TBL] [Abstract][Full Text] [Related]
7. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
[TBL] [Abstract][Full Text] [Related]
8. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
9. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
10. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
[TBL] [Abstract][Full Text] [Related]
11. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
[TBL] [Abstract][Full Text] [Related]
12. Contingent screening for preterm pre-eclampsia.
Wright D; Gallo DM; Gil Pugliese S; Casanova C; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 May; 47(5):554-9. PubMed ID: 26643929
[TBL] [Abstract][Full Text] [Related]
13. Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):308-15. PubMed ID: 25970847
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester contingent screening for small-for-gestational-age neonate.
Nowacka U; Papastefanou I; Bouariu A; Syngelaki A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
[TBL] [Abstract][Full Text] [Related]
15. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
[TBL] [Abstract][Full Text] [Related]
16. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.
Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815
[TBL] [Abstract][Full Text] [Related]
17. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
[TBL] [Abstract][Full Text] [Related]
18. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
[TBL] [Abstract][Full Text] [Related]
19. Screening for pre-eclampsia at 35-37 weeks' gestation.
Panaitescu A; Ciobanu A; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):501-506. PubMed ID: 29896778
[TBL] [Abstract][Full Text] [Related]
20. Prediction of stillbirth from maternal demographic and pregnancy characteristics.
Yerlikaya G; Akolekar R; McPherson K; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Nov; 48(5):607-612. PubMed ID: 27561693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
